Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DSN1 is a structural subunit of the MIS12 kinetochore complex, a core component of the outer kinetochore. The MIS12 complex (MIS12C), which includes DSN1, NSL1, MIS12, and PMF1, acts as a critical bridge linking the inner centromere (CCAN via CENP-C) with the outer kinetochore microtubule-binding sites (NDC80 complex). DSN1 is essential for proper chromosome alignment and segregation during mitosis. Aurora B kinase regulates the MIS12 complex function by phosphorylating DSN1, facilitating kinetochore assembly and tension-sensitive error correction. Disruption of DSN1 impairs kinetochore formation, chromosome segregation, and cell division, leading to chromosomal instability—a hallmark of many cancers[1][2][3][5][6]. DSN1 is not a direct therapeutic target, receptor, or enzyme, but its role in mitosis makes it important for understanding mechanisms of chromosomal instability in disease contexts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DSN1 component of MIS12 kinetochore complex (DSN1).